Cellife Bromelains Quercetin

Nazione: Australia

Lingua: inglese

Fonte: Department of Health (Therapeutic Goods Administration)

Principio attivo:

Nigella sativa, Quantity: 50 mg; Andrographis paniculata, Quantity: 5 mg (Equivalent: Andrographis paniculata, Qty 70 mg); Curcuma longa, Quantity: 2.25 mg (Equivalent: Curcuma longa, Qty 45 mg); bromelains, Quantity: 100 mg; quercetin dihydrate, Quantity: 250 mg

Commercializzato da:

Cellife Health Products Pty Ltd

Forma farmaceutica:

Tablet, film coated

Composizione:

Excipient Ingredients: Acacia; maltodextrin; croscarmellose sodium; microcrystalline cellulose; calcium hydrogen phosphate dihydrate; povidone; crospovidone; magnesium stearate; colloidal anhydrous silica; hypromellose; macrogol 400; titanium dioxide; iron oxide yellow; Carnauba Wax

Via di somministrazione:

Oral

Indicazioni terapeutiche:

Antioxidant/Reduce free radicals formed in the body ; Helps reduce/decrease free radical damage to body cells ; Maintain/support general health and wellbeing ; Anti-inflammatory/relieve inflammation ; Maintain/support healthy digestion ; Aid/assist/helps digestion of (state nutrient) ; Maintain/support immune system health ; Maintain/support healthy immune system function ; Decrease/reduce/relieve the severity of symptoms of mild upper respiratory tract infections ; Relieve symptoms of mild upper respiratory tract infections

Dettagli prodotto:

Visual Identification: ;

Stato dell'autorizzazione:

Listed

Data dell'autorizzazione:

2022-01-31